Header Logo

Connection

Jonathan Kay to Protein Kinase Inhibitors

Back to Details
This is a "connection" page, showing publications Jonathan Kay has written about Protein Kinase Inhibitors.
Jonathan Kay
Connection Strength
0.350
Protein Kinase Inhibitors
  1. Kay J, High WA. Imatinib mesylate treatment of nephrogenic systemic fibrosis. Arthritis Rheum. 2008 Aug; 58(8):2543-8.
    View in: PubMed
    Score: 0.268
  2. Lin HW, Roberts DS, Kay J, Stankovic KM. Sensorineural hearing loss following imatinib (Gleevec) administration. Otolaryngol Head Neck Surg. 2012 Feb; 146(2):335-7.
    View in: PubMed
    Score: 0.082
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.